- Home
- KIDS vs XOMA Comparison
KIDS vs XOMA Comparison
Compare KIDS & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- XOMA
- Stock Information
- Founded
- KIDS 2007
- XOMA 1981
- Country
- KIDS United States
- XOMA United States
- Employees
- KIDS N/A
- XOMA N/A
- Industry
- KIDS Medical/Dental Instruments
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- KIDS Health Care
- XOMA Health Care
- Exchange
- KIDS Nasdaq
- XOMA Nasdaq
- Market Cap
- KIDS 524.3M
- XOMA 457.6M
- IPO Year
- KIDS 2017
- XOMA N/A
- Fundamental
- Price
- KIDS $20.11
- XOMA $37.59
- Analyst Decision
- KIDS Strong Buy
- XOMA Strong Buy
- Analyst Count
- KIDS 7
- XOMA 2
- Target Price
- KIDS $34.14
- XOMA $69.50
- AVG Volume (30 Days)
- KIDS 133.8K
- XOMA 52.3K
- Earning Date
- KIDS 11-05-2025
- XOMA 11-06-2025
- Dividend Yield
- KIDS N/A
- XOMA N/A
- EPS Growth
- KIDS N/A
- XOMA N/A
- EPS
- KIDS N/A
- XOMA N/A
- Revenue
- KIDS $220,733,000.00
- XOMA $44,952,000.00
- Revenue This Year
- KIDS $19.26
- XOMA $88.91
- Revenue Next Year
- KIDS $17.15
- XOMA $13.80
- P/E Ratio
- KIDS N/A
- XOMA N/A
- Revenue Growth
- KIDS 26.08
- XOMA 194.98
- 52 Week Low
- KIDS $16.59
- XOMA $18.35
- 52 Week High
- KIDS $32.00
- XOMA $38.45
- Technical
- Relative Strength Index (RSI)
- KIDS 48.79
- XOMA 69.47
- Support Level
- KIDS $19.30
- XOMA $36.66
- Resistance Level
- KIDS $21.35
- XOMA $38.34
- Average True Range (ATR)
- KIDS 0.84
- XOMA 1.63
- MACD
- KIDS -0.08
- XOMA -0.05
- Stochastic Oscillator
- KIDS 41.18
- XOMA 86.65
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.